These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36769850)

  • 1. Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis.
    Shi JT; Chen N; Xu J; Goyal H; Wu ZQ; Zhang JX; Xu HG
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
    Mao R; Xiao YL; Gao X; Chen BL; He Y; Yang L; Hu PJ; Chen MH
    Inflamm Bowel Dis; 2012 Oct; 18(10):1894-9. PubMed ID: 22238138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Xiang BJ; Jiang M; Sun MJ; Dai C
    Visc Med; 2021 Oct; 37(5):338-348. PubMed ID: 34722717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn's Disease: A Meta-analysis.
    Zhuge Y; Huang QP; Li Q; Wang JS
    Euroasian J Hepatogastroenterol; 2016; 6(2):116-124. PubMed ID: 29201742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity.
    Lin JF; Chen JM; Zuo JH; Yu A; Xiao ZJ; Deng FH; Nie B; Jiang B
    Inflamm Bowel Dis; 2014 Aug; 20(8):1407-15. PubMed ID: 24983982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.
    Trasolini R; Zhu K; Klemm N; Park S; Salh B
    Gastro Hep Adv; 2022; 1(1):45-51. PubMed ID: 39129926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Lorenzo-Gonzalez A; Dominguez-Muñoz JE
    J Clin Gastroenterol; 2018 Mar; 52(3):229-234. PubMed ID: 27984399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis.
    Ye X; Wang Y; Wang HHX; Feng R; Ye Z; Han J; Li L; Zeng Z; Chen M; Zhang S
    Therap Adv Gastroenterol; 2021; 14():1756284821994741. PubMed ID: 33717211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis.
    Tham YS; Yung DE; Fay S; Yamamoto T; Ben-Horin S; Eliakim R; Koulaouzidis A; Kopylov U
    Therap Adv Gastroenterol; 2018; 11():1756284818785571. PubMed ID: 30034529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Calprotectin in Predicting Relapse of Inflammatory Bowel Disease in Children and Adolescents: A Meta-Analysis and Systematic Review.
    Hu T; Wang W; Song F; Zhang W; Yang J
    Pediatr Ann; 2023 Sep; 52(9):e357-e362. PubMed ID: 37695282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
    Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn's disease patients on maintenance treatment with adalimumab.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Lorenzo-Gonzalez A; Dominguez-Muñoz JE
    Scand J Gastroenterol; 2016; 51(4):442-7. PubMed ID: 26595391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn's disease: a systematic review and meta-analysis.
    Xiang B; Dong Z; Dai C
    Rev Esp Enferm Dig; 2021 Mar; 113(3):193-201. PubMed ID: 33207888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.